Angela Wehr

503 total citations
19 papers, 400 citations indexed

About

Angela Wehr is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmaceutical Science. According to data from OpenAlex, Angela Wehr has authored 19 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Psychiatry and Mental health and 3 papers in Pharmaceutical Science. Recurrent topics in Angela Wehr's work include Pharmaceutical studies and practices (8 papers), Schizophrenia research and treatment (6 papers) and Photoreceptor and optogenetics research (2 papers). Angela Wehr is often cited by papers focused on Pharmaceutical studies and practices (8 papers), Schizophrenia research and treatment (6 papers) and Photoreceptor and optogenetics research (2 papers). Angela Wehr collaborates with scholars based in United States, Ireland and Singapore. Angela Wehr's co-authors include Ian A. Blair, Lisa Von Moltke, Kenneth H. Yu, Marjie Hard, Emma E. Furth, Peter J. Weiden, Vineet Sangar, Richard J. Mills, Brian M. Sadler and Doron C. Greenbaum and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Angela Wehr

19 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Wehr United States 11 110 103 86 49 45 19 400
Steve K. Teo Switzerland 16 202 1.8× 121 1.2× 119 1.4× 37 0.8× 57 1.3× 18 634
P. Rolan United Kingdom 10 62 0.6× 189 1.8× 114 1.3× 129 2.6× 46 1.0× 14 619
Beate Beer Austria 11 72 0.7× 38 0.4× 101 1.2× 45 0.9× 32 0.7× 22 362
Dymphy Huntjens Belgium 13 93 0.8× 69 0.7× 110 1.3× 58 1.2× 18 0.4× 28 609
Emma J. Seaber United Kingdom 8 43 0.4× 208 2.0× 74 0.9× 39 0.8× 25 0.6× 10 509
Esther Kim United States 11 354 3.2× 71 0.7× 117 1.4× 23 0.5× 30 0.7× 19 609
Launa J. Aspeslet Canada 14 99 0.9× 55 0.5× 45 0.5× 107 2.2× 37 0.8× 24 598
Regina M. Leger United States 15 82 0.7× 31 0.3× 27 0.3× 69 1.4× 34 0.8× 37 692
Reynold C. Ly United States 12 131 1.2× 25 0.2× 77 0.9× 105 2.1× 26 0.6× 23 394
Yiping Liu China 14 117 1.1× 38 0.4× 148 1.7× 48 1.0× 188 4.2× 24 765

Countries citing papers authored by Angela Wehr

Since Specialization
Citations

This map shows the geographic impact of Angela Wehr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Wehr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Wehr more than expected).

Fields of papers citing papers by Angela Wehr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Wehr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Wehr. The network helps show where Angela Wehr may publish in the future.

Co-authorship network of co-authors of Angela Wehr

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Wehr. A scholar is included among the top collaborators of Angela Wehr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Wehr. Angela Wehr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ma, Bin, Lei Zhang, Lihong Sun, et al.. (2021). Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546. ACS Medicinal Chemistry Letters. 12(7). 1124–1129. 5 indexed citations
2.
Nguyen, David P., Anne C. Smith, E. Hoffman, et al.. (2020). Mechanistic PK/PD Model of Neuroactive Steroid GABAA Positive Allosteric Modulation and Effects on TETRAS Assessment in Essential Tremor (4499). Neurology. 94(15_supplement). 1 indexed citations
4.
Sommi, Roger W., et al.. (2020). Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals. CNS Spectrums. 27(3). 262–267. 6 indexed citations
6.
Jain, Rakesh K., Jonathan M. Meyer, Angela Wehr, et al.. (2019). Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia. CNS Spectrums. 25(3). 323–330. 20 indexed citations
9.
Hard, Marjie, Angela Wehr, Brian M. Sadler, Richard J. Mills, & Lisa Von Moltke. (2018). Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil. European Journal of Drug Metabolism and Pharmacokinetics. 43(4). 461–469. 25 indexed citations
10.
Hard, Marjie, Angela Wehr, Yangchun Du, et al.. (2018). Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia. Journal of Clinical Psychopharmacology. 38(5). 435–441. 15 indexed citations
11.
Wehr, Angela, Marjie Hard, Miao Yu, Richard Leigh-Pemberton, & Lisa Von Moltke. (2018). Relative Bioavailability of Monomethyl Fumarate after Administration of ALKS 8700 and Dimethyl Fumarate in Healthy Subjects (P1.403). Neurology. 90(15_supplement). 8 indexed citations
12.
Walling, David P., Marjie Hard, Angela Wehr, et al.. (2018). F197. Aripiprazole Lauroxil NanoCrystal® Dispersion: A Potential 1-Day Initiation Regimen for Long-Acting Aripiprazole Lauroxil. Biological Psychiatry. 83(9). S315–S315. 2 indexed citations
13.
Hard, Marjie, Richard J. Mills, Brian M. Sadler, et al.. (2017). Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model. CNS Drugs. 31(7). 617–624. 36 indexed citations
14.
Oppenheimer, Stacey R. & Angela Wehr. (2015). Imaging Mass Spectrometry in Drug Discovery and Development. Bioanalysis. 7(20). 2609–2610. 8 indexed citations
15.
Wehr, Angela, Wei‐Ting Hwang, Ian A. Blair, & Kenneth H. Yu. (2012). Relative Quantification of Serum Proteins from Pancreatic Ductal Adenocarcinoma Patients by Stable Isotope Dilution Liquid Chromatography–Mass Spectrometry. Journal of Proteome Research. 11(3). 1749–1758. 23 indexed citations
16.
Chandramohanadas, Rajesh, et al.. (2011). The Malaria Parasite Progressively Dismantles the Host Erythrocyte Cytoskeleton for Efficient Egress. Molecular & Cellular Proteomics. 10(12). M111.010678–M111.010678. 63 indexed citations
17.
Wehr, Angela, Emma E. Furth, Vineet Sangar, Ian A. Blair, & Kenneth H. Yu. (2011). Analysis of the Human Pancreatic Stellate Cell Secreted Proteome. Pancreas. 40(4). 557–566. 76 indexed citations
18.
Wehr, Angela, Ian A. Blair, & Kaihuan Yu. (2011). Tumor microenvironment derived biomarkers for the early detection of pancreatic cancer (PDAC).. Journal of Clinical Oncology. 29(15_suppl). e14591–e14591. 1 indexed citations
19.
Lee, Seon Hwa, Kannan Rangiah, Michelle V. Williams, et al.. (2007). Cyclooxygenase-2-Mediated Metabolism of Arachidonic Acid to 15-Oxo-eicosatetraenoic Acid by Rat Intestinal Epithelial Cells. Chemical Research in Toxicology. 20(11). 1665–1675. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026